Jonathan Jay Mazelsky - Nov 14, 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
President & CEO, Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan Jay Mazelsky
Stock symbol
IDXX
Transactions as of
Nov 14, 2022
Transactions value $
-$3,384,036
Form type
4
Date filed
11/16/2022, 04:00 PM
Previous filing
Nov 9, 2022
Next filing
Feb 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $1.18M +19K +30.49% $62.00* 81.3K Nov 14, 2022 Direct
transaction IDXX Common Stock Sale -$421K -972 -1.2% $433.37 80.3K Nov 14, 2022 Direct F1
transaction IDXX Common Stock Sale -$2.77M -6.39K -7.95% $434.26 73.9K Nov 14, 2022 Direct F2
transaction IDXX Common Stock Sale -$1.11M -2.54K -3.44% $435.07 71.4K Nov 14, 2022 Direct F3
transaction IDXX Common Stock Sale -$262K -600 -0.84% $435.88 70.8K Nov 14, 2022 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -19K -100% 0 Nov 14, 2022 Common Stock 19K $62.00 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average price of the shares sold ranging from a low of $432.67 to a high of $433.65 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F2 Represents the weighted average price of the shares sold ranging from a low of $433.69 to a high of $434.685 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F3 Represents the weighted average price of the shares sold ranging from a low of $434.70 to a high of $435.67 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F4 Represents the weighted average price of the shares sold ranging from a low of $435.77 to a high of $436.04 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F5 Grant of option to buy 9,499 shares of Issuer common stock that became exercisable for 8,244 shares in four equal annual installments beginning February 14, 2015 and for the remaining 1,255 shares on February 14, 2019 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
F6 Not applicable.